At The Medicines Company, we strive to improve health outcomes for patients, physicians and providers.

In the United States, we currently we have three marketed products that span two areas: acute cardiovascular care and infectious disease care. To learn more about our U.S. marketed products, click here.

Additionally, we have marketing authorization for many of our products in the European Union and other markets outside of the United States. To learn more about our various global marketed products and the countries where they are approved, click here.